Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; duplication/deletion variants

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 81203 pertains to the molecular genetic testing specifically aimed at identifying duplication and deletion variants of the adenomatous polyposis coli (APC) gene. This gene is crucial in the context of familial adenomatosis polyposis (FAP), a hereditary condition characterized by the development of numerous polyps in the colon and rectum, which can lead to colorectal cancer if left untreated. FAP is inherited in an autosomal dominant manner, meaning that an individual only needs to inherit the mutated gene from one parent to be affected by the condition. The classic form of FAP is typically more severe than its attenuated counterpart, which presents with fewer polyps and a later onset of symptoms. The APC gene plays a vital role as a tumor suppressor, and mutations in this gene disrupt its function, leading to uncontrolled cell growth and polyp formation. The gene is located on chromosome 5, and over 700 distinct mutations have been documented, many of which result in a truncated, nonfunctional APC protein. The testing associated with CPT® Code 81203 is essential for detecting specific genetic alterations that may predispose individuals to colorectal cancer, thereby facilitating early intervention and management strategies. This code is specifically used for testing that identifies duplication or deletion variants, which are critical for understanding the genetic basis of the disease and for guiding patient care.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The molecular genetic testing represented by CPT® Code 81203 is indicated for individuals who are suspected of having familial adenomatosis polyposis (FAP) due to a family history of the condition or the presence of multiple colorectal polyps. This testing is particularly relevant for:

  • Familial Adenomatous Polyposis (FAP) Individuals with a known family history of FAP, which is characterized by the development of numerous adenomatous polyps in the colon and rectum.
  • Attenuated FAP Patients exhibiting fewer polyps and a later onset of symptoms, who may still carry mutations in the APC gene.
  • Genetic Counseling Individuals seeking genetic counseling to understand their risk of developing colorectal cancer based on their genetic background.
  • Screening for Known Variants Family members of individuals with identified APC gene mutations who require testing to determine if they also carry the mutation.

2. Procedure

The procedure for CPT® Code 81203 involves several key steps to accurately identify duplication and deletion variants of the APC gene:

  • Sample Collection A biological sample, typically blood or saliva, is collected from the patient. This sample contains the DNA necessary for genetic analysis.
  • DNA Extraction The DNA is extracted from the collected sample using laboratory techniques that isolate the genetic material for further analysis.
  • Genetic Analysis The extracted DNA undergoes molecular genetic testing specifically designed to detect duplication and deletion variants within the APC gene. This may involve techniques such as polymerase chain reaction (PCR) and sequencing methods.
  • Data Interpretation The results of the genetic analysis are interpreted by qualified laboratory personnel, who assess the presence of any identified variants and their potential implications for the patient’s health.
  • Reporting A comprehensive report is generated, detailing the findings of the genetic test, including any identified mutations and their association with familial adenomatosis polyposis.

3. Post-Procedure

After the completion of the genetic testing associated with CPT® Code 81203, patients may receive counseling regarding the results. If a mutation is identified, genetic counseling is recommended to discuss the implications for the patient and their family members, including the risk of developing colorectal cancer and the need for surveillance or preventive measures. Patients may also be advised on lifestyle modifications and screening protocols based on their genetic risk. Follow-up appointments may be scheduled to monitor the patient's health and to discuss any further testing or interventions that may be necessary.

Short Descr APC GENE DUP/DELET VARIANTS
Medium Descr APC GENE ANALYSIS DUPLICATION/DELETION VARIANTS
Long Descr APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; duplication/deletion variants
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Service Paid under Fee Schedule or Payment System other than OPPS
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T2D - Other tests - other
MUE 1
CCS Clinical Classification 234 - Pathology
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Date
Action
Notes
2013-01-01 Added Added
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"